These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 32105362)
21. PD-L1 Nanobody Competitively Inhibits the Formation of the PD-1/PD-L1 Complex: Comparative Molecular Dynamics Simulations. Sun X; Yan X; Zhuo W; Gu J; Zuo K; Liu W; Liang L; Gan Y; He G; Wan H; Gou X; Shi H; Hu J Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986511 [TBL] [Abstract][Full Text] [Related]
22. Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy. Liu H; Zhao Z; Zhang L; Li Y; Jain A; Barve A; Jin W; Liu Y; Fetse J; Cheng K J Immunother Cancer; 2019 Oct; 7(1):270. PubMed ID: 31640814 [TBL] [Abstract][Full Text] [Related]
23. An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy. Abdolmaleki S; Ganjalikhani Hakemi M; Ganjalikhany MR PLoS One; 2024; 19(7):e0304270. PubMed ID: 39052609 [TBL] [Abstract][Full Text] [Related]
24. Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1. Guzik K; Zak KM; Grudnik P; Magiera K; Musielak B; Törner R; Skalniak L; Dömling A; Dubin G; Holak TA J Med Chem; 2017 Jul; 60(13):5857-5867. PubMed ID: 28613862 [TBL] [Abstract][Full Text] [Related]
25. Kaempferol and Its Glycoside, Kaempferol 7-O-Rhamnoside, Inhibit PD-1/PD-L1 Interaction In Vitro. Kim JH; Kim YS; Choi JG; Li W; Lee EJ; Park JW; Song J; Chung HS Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375257 [TBL] [Abstract][Full Text] [Related]
26. Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy. Zhang H; Xia Y; Yu C; Du H; Liu J; Li H; Huang S; Zhu Q; Xu Y; Zou Y Molecules; 2021 Jun; 26(11):. PubMed ID: 34199417 [TBL] [Abstract][Full Text] [Related]
27. Nanoparticle Conjugation Stabilizes and Multimerizes β-Hairpin Peptides To Effectively Target PD-1/PD-L1 β-Sheet-Rich Interfaces. Jeong WJ; Bu J; Han Y; Drelich AJ; Nair A; Král P; Hong S J Am Chem Soc; 2020 Jan; 142(4):1832-1837. PubMed ID: 31895555 [TBL] [Abstract][Full Text] [Related]
28. The Too Many Faces of PD-L1: A Comprehensive Conformational Analysis Study. Ahmed M; Barakat K Biochemistry; 2017 Oct; 56(40):5428-5439. PubMed ID: 28898057 [TBL] [Abstract][Full Text] [Related]
29. PD-L1/PD-1 axis as a potent therapeutic target in breast cancer. Bastaki S; Irandoust M; Ahmadi A; Hojjat-Farsangi M; Ambrose P; Hallaj S; Edalati M; Ghalamfarsa G; Azizi G; Yousefi M; Chalajour H; Jadidi-Niaragh F Life Sci; 2020 Apr; 247():117437. PubMed ID: 32070710 [TBL] [Abstract][Full Text] [Related]
30. Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy. Liu H; Bi X; Zhou Y; Shi R; Yao S; Qi J; Feng H; Feng M; Yan J; Tan S Signal Transduct Target Ther; 2020 Aug; 5(1):158. PubMed ID: 32839442 [No Abstract] [Full Text] [Related]
32. Probing protein flexibility reveals a mechanism for selective promiscuity. Pabon NA; Camacho CJ Elife; 2017 Apr; 6():. PubMed ID: 28432789 [TBL] [Abstract][Full Text] [Related]
33. Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature. Kopalli SR; Kang TB; Lee KH; Koppula S Recent Pat Anticancer Drug Discov; 2019; 14(2):100-112. PubMed ID: 30370857 [TBL] [Abstract][Full Text] [Related]
34. Molecular Mechanism of Food-Derived Polyphenols on PD-L1 Dimerization: A Molecular Dynamics Simulation Study. Guo Y; Liang J; Liu B; Jin Y Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681584 [TBL] [Abstract][Full Text] [Related]
35. The design of high affinity human PD-1 mutants by using molecular dynamics simulations (MD). Du J; Qin Y; Wu Y; Zhao W; Zhai W; Qi Y; Wang C; Gao Y Cell Commun Signal; 2018 Jun; 16(1):25. PubMed ID: 29879980 [TBL] [Abstract][Full Text] [Related]
36. Residue-specific binding mechanisms of PD-L1 to its monoclonal antibodies by computational alanine scanning. Wen W; Huang D; Bao J; Zhang JZH Phys Chem Chem Phys; 2021 Jul; 23(29):15591-15600. PubMed ID: 34259259 [TBL] [Abstract][Full Text] [Related]
37. Recent advances in the clinical development of immune checkpoint blockade therapy. Ghahremanloo A; Soltani A; Modaresi SMS; Hashemy SI Cell Oncol (Dordr); 2019 Oct; 42(5):609-626. PubMed ID: 31201647 [TBL] [Abstract][Full Text] [Related]